# Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents

> **NCT01563952** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 400 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Non-IVUS guided intervention with Endeavor Resolute stent (zotarolimus-eluting stent, Medtronic)
- **DEVICE:** IVUS guided intervention with Endeavor Resolute stent (zotarolimus-eluting stent, Medtronic)
- **DEVICE:** Non-IVUS guided intervention with Nobori stent (biolimus A9-eluting stent, Terumo)
- **DEVICE:** IVUS guided intervention with Nobori stent (biolimus A9-eluting stent, Terumo)

## Key facts

- **NCT ID:** NCT01563952
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2012-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01563952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01563952, "Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01563952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*